References
- Pels R, Sterry W, Lademann J. Clobetasol propionate-were, when, why? Drugs Today (Barc). 2008;44:547–557.
- Joly P, Roujeau JC, Benichou J, Picard C, et al A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med. 2002;346:321–327.
- Carbone M, Goss E, Carrozzo M, Castellano S, Conrotto D, Broccoletti R, et al Systemic and topical corticosteroid treatment of oral liche planus: a comparative study with long-term follow up. J Oral Pathol Med. 2003;32:323–329.
- Pramick M, Whitmore SE. Cushing's syndrome caused by mucosal corticosteroid therapy. Int J Dermatol. 2009;48:100–101.
- Van Tuyl SA, Slee PH. Are the effects of local treatment with glucocorticoids only local? Neth J Med. 2002;60:130–132.
- Lodi G, Tarozzi M, Sardella A, Demarosi F, Canegallo L, Di Benedetto D, et al Miconazole as adjuvant therapy for oral lichen planus: a double-blind randomized controlled trial. Br J Dermatol. 2007;156:1336–1341.
- Lozada-Nur F, Robinson J, Regezi JA. Oral hairy leukoplakia in nonimmunosuppressed patients: report of four cases. Oral Surg Oral Med Oral Pathol Radiol Endod. 1994;78:599–602.
- González-Moles MA, Scully C. Vesciculo-erosive oral mucosal disease-Management with topical corticosteroids: (1) Fundamental principles and specific agents available. J Dent Res. 2005;84:294–301.
- González-Moles MA, Scully C. Vesciculo-erosive oral mucosal desease-Management with topical corticosteroids: (2) Protocols, monitoring of effects and adverse reactions, and the future. J Dent Res. 2005;84:302–308.
- Thongprasom K, Dhanuthai K. Steroids in the treatment of lichen planus: a review. J Oral Sci. 2008;50:377–385.
- Boscaro M, Arnaldi G. Approach to the patient with possible Cushing syndrome. J Clin Endocrinol Metab. 2009;94:3121–3131.
- Yuan H, Huang LF, Du YZ, Ying XY, You J, Hu FQ, et al Solid lipid nanoparticles prepared by solvent diffusion method in a nanoreactor system. Colloids Surf B Biointerfaces. 2008;61:132–137.
- Abma EM, Blanken R, De Heide LJ. Cushing's syndrome caused by topical steroid therapy for psoriasis. Neth J Med. 2002;60:148–150.
- Carbone M, Arduino PG, Carrozzo M, Caiazzo G, Broccoletti R, Conrotto D, et al Topical clobetasol in the treatment of atrophic-erosive oral lichen planus: a randomized controlled trial to compare two preparations with different concentrations. J Oral Pathol Med. 2009;38:227–233.
- Lodi G, Scully C, Carrozzo M, Griffiths M, Sugerman PB, Thongprasom K. Current controversies in oral lichen planus: report of an international consensus meeting. Part 2. Clinical management and malignant transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100:164–178.
- Ismail SB, Kumar SK, Zain RB. Oral lichen planus and lichenoid reactions: etiopathogenesis, diagnosis, management and malignant transformation. J Oral Sci. 2007;49:89–106.
- Lodi G, Varoni E, Salis A, Franchini R. Oral lichen planus and lichenoid lesions. A guide for the dentist. Dental Cadmos. 2011; doi: 10.1016/j.cadmos.2011.07.004.
- Thongprasom K, Carrozzo M, Furness S, Lodi G. Interventions for treating oral lichen planus. Cochrane Database Syst Rev. 2011;CD001168.
- Becker JC, Houben R, Vetter CS, Bröcker EB. The carcinogenic potential of tacrolimus ointment beyond immune suppression: a hypothesis creating case report. BMC Cancer. 2006;11:6–7.
- Al Johani KA, Hegarty AM, Porter SR, Fedele S. Calcineurin inhibitors in oral medicine. J Am Acad Dermatol. 2009;61:829–840.
- Atabek ME, Pirgon O, Unal E. Pituitary-adrenal axis suppression due to topical steroid administration in an infant. Pediatr Int. 2007;49:242–244.
- Szabó V, Borgulya G, Filkorn T, Majnik J, Bányász I, Nagy ZZ. The variant N363S of glucocorticoid receptor in steroid-induced ocular hypertension in Hungarian patients treated with photorefractive keratectomy. Mol Vis. 2007;27:659–666.
- Jewell CM, Cidlowski JA. Molecular evidence for a link between the N363S glucocorticoid receptor polymorphism and altered gene expression. J Clin Endocrinol Metab. 2007;92:3268–3277.
- Ida S, Nakamura Y, Fujii H, et al A patient with hypocortisolism and Cushing's syndrome-like manifestations: cortisol hyperreactive syndrome. J Clin Endocrinol Metab. 1990;70:729–737.
- Huizenga NA, Koper JW, De Lange P, et al A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab. 1998;83:144–151.
- Tempark T, Phatarakijnirund V, Chatproedprai S, Watcharasindhu S, Supornsilchai V, Wananukul S. Exogenous Cushing's syndrome due to topical corticosteroid application: case report and review literature. Endocrine. 2010;38:328–334.
- Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54:1–15.
- González-Moles MA. The use of topical corticoids in oral pathology. Med Oral Patol Oral Cir Bucal. 2010;15:e827–e831.
- Al-Khenaizan S, Al Alwan I. Topical steroid-induced Cushing syndrome. Ann Saudi Med. 2008;28:300–302.
- Varoni EM, Molteni A, Sardella A, Carrassi A, Di Candia D, Gigli F, et al Pharmacokinetics study about topical Clobetasol on oral mucosa. J Oral Pathol Med. 2012;41:255–260.